Evidence map›Paper›PMID 42421850›Full record

ArticleEuropean heart journal. Digital health2026

Prediction of appropriate implantable cardioverter-defibrillator therapy using machine learning and routinely available clinical data.

Toshinori Chiba, Serafina Wegner, Emanuel Heil, Verena Tscholl, Robert Haettasch, Patrick Nagel, Johannes Lucas, Nikolaos Dagres, Felix Balzer, Alexander Meyer and 4 more

Abstract read
In one paragraph

Article in European heart journal. Digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Toshinori ChibaDepartment of Cardiology, Deutsches Herzzentrum der Charité, Charitéplatz 1, 10117 Berlin, Germany.ORCID https://orcid.org/0009-0002-8386-7592
Serafina WegnerDepartment of Cardiology, Deutsches Herzzentrum der Charité, Charitéplatz 1, 10117 Berlin, Germany.
Emanuel HeilDepartment of Cardiology, Deutsches Herzzentrum der Charité, Charitéplatz 1, 10117 Berlin, Germany.ORCID https://orcid.org/0000-0001-9782-8311
Verena TschollDepartment of Cardiology, Deutsches Herzzentrum der Charité, Charitéplatz 1, 10117 Berlin, Germany.ORCID https://orcid.org/0000-0003-2748-2540
Robert HaettaschDepartment of Cardiology, Deutsches Herzzentrum der Charité, Charitéplatz 1, 10117 Berlin, Germany.ORCID https://orcid.org/0000-0001-6276-0847
Patrick NagelDepartment of Cardiology, Deutsches Herzzentrum der Charité, Charitéplatz 1, 10117 Berlin, Germany.ORCID https://orcid.org/0009-0009-0921-1190
Johannes LucasDepartment of Cardiology, Deutsches Herzzentrum der Charité, Charitéplatz 1, 10117 Berlin, Germany.ORCID https://orcid.org/0009-0006-3421-3866
Nikolaos DagresDepartment of Cardiology, Deutsches Herzzentrum der Charité, Charitéplatz 1, 10117 Berlin, Germany.ORCID https://orcid.org/0000-0003-0323-4956
Felix BalzerInstitute of Medical Informatics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Invalidenstraße 90, 10115 Berlin, Germany.ORCID https://orcid.org/0000-0003-1575-2056
Alexander MeyerInstitute of Artificial Intelligence in Medicine, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Wilhelm HaverkampDepartment of Cardiology, Deutsches Herzzentrum der Charité, Charitéplatz 1, 10117 Berlin, Germany.ORCID https://orcid.org/0000-0002-6183-2519
Florian BlaschkeDepartment of Cardiology, Deutsches Herzzentrum der Charité, Charitéplatz 1, 10117 Berlin, Germany.
Gerhard HindricksDepartment of Cardiology, Deutsches Herzzentrum der Charité, Charitéplatz 1, 10117 Berlin, Germany.ORCID https://orcid.org/0000-0002-0132-0773
Felix HohendannerDepartment of Cardiology, Deutsches Herzzentrum der Charité, Charitéplatz 1, 10117 Berlin, Germany.ORCID https://orcid.org/0000-0002-0194-4615

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: Risk stratification for appropriate implantable cardioverter-defibrillator (ICD) therapy remains imprecise when based on conventional clinical variables alone. We aimed to develop and geographically validate a machine-learning model that integrates routinely available clinical, electrocardiogram, and device interrogation/programming parameters, and quantify the incremental value of non-sustained ventricular tachycardia (NSVT). Methods and results: We retrospectively analysed 514 ICD recipients implanted between 2020 and 2025 at two hospital sites (development cohort) and an independent cohort of 220 patients from a third site (external validation). The endpoint was appropriate ICD therapy (anti-tachycardia pacing or shock). Models were trained using nested stratified cross-validation in the development cohort, and the final refitted model was applied to the external cohort without recalibration. In the development cohort, 77/514 patients (15%) experienced appropriate ICD therapy (follow-up 404 days). A base model (histogram-based gradient boosting) excluding NSVT achieved modest discrimination [receiver operating characteristic (ROC)-area under the curve (AUC) 0.624; average precision 0.198]. Adding NSVT improved performance (ROC-AUC 0.805; average precision 0.432). Logistic regression with NSVT achieved comparable discrimination (ROC-AUC 0.78; average precision 0.43), indicating a largely NSVT-driven gain. External validation (event rate 51/220, 23%) confirmed good discrimination (ROC-AUC 0.815; average precision 0.583) with acceptable calibration (Brier score 0.137). At the pre-specified threshold of 0.16 in external validation, sensitivity was 0.78 and specificity was 0.74. Conclusion: A machine-learning model integrating routinely available clinical, electrocardiogram, and ICD programming/interrogation data may enable the prediction of appropriate ICD therapy with preserved performance on geographic external validation. NSVT was the dominant contributor to predictive performance across modelling approaches.

Indexed as

Implantable cardioverter-defibrillatorMachine learningNon-sustained ventricular tachycardiaRisk stratificationVentricular arrhythmia

Identifiers

PMID42421850
PMCPMC13344847

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.